Investigating the stratified efficacy and safety of pharmacological blood pressure-lowering: an overall protocol for individual patient-level data meta-analyses of over 300 000 randomised participants in the new phase of the Blood Pressure Lowering Treatment Trialists’ Collaboration (BPLTTC)
Main Authors: | Rahimi, K, Canoy, D, Nazarzadeh, M, Salimi-Khorshidi, G |
---|---|
Format: | Journal article |
Published: |
BMJ
2019
|
Similar Items
-
The Blood Pressure Lowering Treatment Trialists’ Collaboration: methodological clarifications of recent reports
by: Nazarzadeh, M, et al.
Published: (2022) -
Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis
by: Rahimi, K, et al.
Published: (2021) -
Intensive blood pressure lowering and risk of diabetes: Friend or foe?
by: Nazarzadeh, M, et al.
Published: (2019) -
Systolic blood pressure, chronic obstructive pulmonary disease and cardiovascular risk
by: Rao, S, et al.
Published: (2023) -
Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists' Collaboration.
by: Neal, B, et al.
Published: (2000)